Treatment of Breast and Lung Cancer Cells with a N-7 Benzyl Guanosine Monophosphate Tryptamine Phosphoramidate Pronucleotide (4Ei-1) Results in Chemosensitization to Gemcitabine and Induced eIF4E Proteasomal Degradation

2013

Treatment of Breast and Lung Cancer Cells with a N-7 Benzyl Guanosine Monophosphate Tryptamine Phosphoramidate Pronucleotide (4Ei-1) Results in Chemosensitization to Gemcitabine and Induced eIF4E Proteasomal Degradation
Molecular Pharmaceutics (2013)

The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.

Disclaimer

Shui Li

Associate

Related Publications

Fall 2021
Are All Fiduciaries Created Equal?
Erica Ramsey - The Robins Kaplan Spotlight, Vol. 6, No. 3
Fall 2021
Context Matters: Fiduciaries and the Rule Against Self-Dealing
Brendan Johnson, Tim Billion - The Robins Kaplan Spotlight, Vol. 6, No. 3
Fall 2021
Update on DOL Fiduciary Rule
Michael Reif - The Robins Kaplan Spotlight, Vol. 6, No. 3
September 28, 2021
Briefly: Federal appeals: How much notice is enough?
Stephen Safranski and Geoffrey Kozen - Minnesota Lawyer
Summer 2021
IATL President's Letter on Judicial Security
Roman Silberfeld - The Robins Kaplan Quarterly: Tackling Tough Business Litigation Matters
Back to Top